David Shitrit
Overview
Explore the profile of David Shitrit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
1481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Epstein Shochet G, Bardenstein-Wald B, McElroy M, Kukuy A, Surber M, Edelstein E, et al.
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33805152
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis. The IPF-conditioned matrix (IPF-CM) system enables the study of matrix-fibroblast interplay. While effective at slowing fibrosis, nintedanib has...
12.
Guber E, Wand O, Epstein Shochet G, Romem A, Shitrit D
Respiration
. 2021 Mar;
100(5):423-431.
PMID: 33784708
Background: Sarcoidosis is a heterogeneous multisystemic disorder of unknown etiology. Dyspnea and fatigue are two of the most common and debilitating symptoms experienced by subjects with sarcoidosis. There is limited...
13.
Epstein Shochet G, Pomerantz A, Shitrit D, Bardenstein-Wald B, Ask K, Surber M, et al.
Ther Adv Chronic Dis
. 2021 Mar;
11:2040622320968412.
PMID: 33708368
Background And Aims: Idiopathic pulmonary fibrosis (IPF) is a common and severe form of pulmonary fibrosis. Nintedanib, a triple angiokinase inhibitor, is approved for treating IPF. Galectin 3 (Gal-3) activates...
14.
Epstein Shochet G, Israeli-Shani L, Kains I, Wand O, Shitrit D
BMC Pulm Med
. 2021 Jan;
21(1):1.
PMID: 33402146
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease that causes scarring of the lungs. The disease is associated with the usual interstitial pneumonia pattern, which was not yet...
15.
Erez D, Israeli-Shani L, Epstein Shochet G, King D, Abu-Akel M, Dovrish Z, et al.
Isr Med Assoc J
. 2020 Dec;
22(12):747-751.
PMID: 33381945
Background: Primary spontaneous pneumothorax (PSP) tends to occur in young adults without underlying lung diseases and is usually followed by limited symptoms, while secondary spontaneous pneumothorax (SSP) is a complication...
16.
Gaga M, Chorostowska-Wynimko J, Horvath I, Tammemagi M, Shitrit D, Eisenberg V, et al.
Eur Respir J
. 2020 Oct;
57(1).
PMID: 33122336
Aim: Lung cancer screening reduces mortality. We aim to validate the performance of Lung EpiCheck, a six-marker panel methylation-based plasma test, in the detection of lung cancer in European and...
17.
Abd El-Qader E, Israeli-Shani L, Epstein Shochet G, Dovrish Z, King D, Dahan D, et al.
Isr Med Assoc J
. 2020 Oct;
22(10):618-622.
PMID: 33070485
Background: Patients with severe chronic obstructive pulmonary disease (COPD) experience frequent exacerbations and need to be hospitalized, resulting in an economic and social burden. Although data exist regarding reasons of...
18.
Epstein-Shochet G, Pham S, Beck S, Naiel S, Mekhael O, Revill S, et al.
Pulm Pharmacol Ther
. 2020 Aug;
63:101933.
PMID: 32750409
Oral nintedanib is marketed for the treatment of idiopathic pulmonary fibrosis (IPF). While effective slowing fibrosis progression, as an oral medicine nintedanib is limited. To reduce side effects and maximize...
19.
Epstein Shochet G, Brook E, Bardenstein-Wald B, Grobe H, Edelstein E, Israeli-Shani L, et al.
Ther Adv Chronic Dis
. 2020 Jul;
11:2040622320936023.
PMID: 32637060
Background And Objective: The term 'fibroblast' covers a heterogeneous cell population in idiopathic pulmonary fibrosis (IPF). The fibroblasts are considered as main effector cells, because they promote disease progression by...
20.
Koslow M, Epstein Shochet G, Fenadka F, Neuman Y, Osadchy A, Shitrit D
Am J Med Sci
. 2020 May;
360(2):129-136.
PMID: 32466857
Background: Thrombolytic therapy is widely accepted for massive pulmonary embolism (PE) due to the high mortality risk associated with standard anticoagulation alone. Its role in submassive PE, however, has remained...